Scale -

  • Ebitda is 959 Rs Cr; Annual Growth is 20 %; Continuous Growth over 3 years; in Top Quartile
  • Revenue is 4982 Rs Cr; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 12 %
  • PBT is 203 Rs Cr; Continuous Growth over 3 years; in Top Quartile
  • Quarterly Revenue is 1392 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile
  • Quarterly Ebitda is 325 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile

Profitability -

  • PBDIT Margin is 19.24 %; Continuous Growth over 3 years
  • Quarterly Ebitda Margin is 23 %; Continuous Growth over 3 Quarters; in Top Quartile
  • Quarterly Profit margin is 11 %; Continuous Growth over 3 Quarters
  • PAT Margin is 6.92 %; Annual Decline is -13 %; 5 Year CAGR is -10 %

Return -

  • ROE is 8.76 %; Annual Decline is -37 %; Continuous Decline over 3 years; 5 Year CAGR is -18 %
  • ROCE is 10.98 %; Continuous Decline over 3 years; 5 Year CAGR is -17 %
  • ROA is 4.43 %; Continuous Decline over 3 years; 5 Year CAGR is -17 %
  • Asset Turnover is 68 %; Continuous Decline over 3 years

Efficiency -

  • Current Ratio is 1.43; Annual Growth is 32 %; Continuous Growth over 3 years; in Bottom Quartile
  • Quick Ratio is 0.68; Annual Growth is 42 %; Continuous Growth over 3 years; in Bottom Quartile
  • Operating cash flow is 502 Rs Cr; in Top Quartile; Annual Decline is -30 %
  • Inventory Turnover Ratio is 4.25; 5 Year CAGR is 33 %

Solvancy -

  • Debt/Equity is 0.52; Annual Decline is -45 %; in Top Quartile
  • Long term Debt is 1558 Rs Cr; in Top Quartile
  • Total Debt is 2059 Rs Cr; in Top Quartile
  • Contingent Liabilities is 1256 Rs Cr; in Top Quartile; 5 Year CAGR is 31 %

Quality -

  • Exceptional Items/PBT is -3 %; Annual Decline is -141 %
  • Current Tax/PAT is 15 %; Annual Decline is -47 %; Continuous Decline over 3 years; 5 Year CAGR is -24 %
  • Operating cashflow/ebitda is 52 %; Annual Decline is -42 %
  • Operating cashflow/PAT is 145 %; Annual Decline is -26 %; Continuous Decline over 3 years
  • Change in Inventories/Total Expenses is 0 %; Annual Growth is 98 %
  • Other Expenses/Total Expenses is 46 %; Continuous Growth over 3 years

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Five Stocks To Buy Today, October 27: Dr Reddy's Laboratories, Asahi India Glass, Ajanta Pharma, And More
Read More
  • Past/current